Healthcare - Biotechnology - NASDAQ - US
$ 2.58
45.8 %
$ 6.99 M
Market Cap
-0.6
P/E
INCOME STATEMENT
0
REVENUE
-9.65 M
OPERATING INCOME
-5.26 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Cyclerion Therapeutics, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 9.65 M |
| Operating Income | -9.65 M |
| Other Expenses | -4.38 M |
| Net Income | -5.26 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 0 | 0.3 | 3.3 | 2.3 | 4.5 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 0 | 65 K | 0.5 | 0 | 0 | 1.5 | 1.7 | 2.2 |
| Gross Profit | 0 | 0.2 | 2.8 | 2.3 | 4.5 | (1.5) | (1.7) | (2.2) |
| OPERATING INCOME | ||||||||
| Operating Expenses | 9.6 | 44.7 | 57.6 | 85.2 | 129.5 | 115.3 | 93.9 | 61.4 |
| Selling, General and Administrative Expenses | 8.1 | 14.5 | 20.6 | 28.8 | 34.4 | 27.5 | 15.1 | 10.5 |
| Research and Development Expenses | 1.5 | 31.5 | 37.6 | 56.4 | 95.1 | 87.7 | 78.8 | 50.9 |
| Operating Income | (9.6) | (44.4) | (55.2) | (81.3) | (125.0) | (115.3) | (93.9) | (63.6) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 0 | 0.3 | 16 K | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | (2.9) | 0.3 | 3.5 | 3.5 | 2.0 | 0 | 0 | 0 |
| Pre-Tax Income | (12.6) | (44.1) | (51.6) | (77.8) | (123.0) | (115.3) | (93.9) | (63.6) |
| NET INCOME | ||||||||
| Tax Provision | 0 | (0.3) | 16 K | (5.1) | (2.0) | 1.4 | 0 | 0 |
| Net Income | (21.0) | (43.8) | (51.7) | (72.7) | (121.0) | (115.3) | (93.9) | (63.6) |
| EPS | 8.99 | 20.1 | 26.4 | 47.8 | 88.4 | 84.4 | 68.8 | 46.4 |